We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioInvent updates on the progress of the Phase II trial of the long acting anticoagulant TB-402

News   Sep 23, 2009

 
BioInvent updates on the progress of the Phase II trial of the long acting anticoagulant TB-402
 
 
 

RELATED ARTICLES

Mathematical Method Provides Deeper Understanding of Drug Interactions

News

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences have developed a new methodology characterizing more precisely how drugs influence each other when combined during treatment.

READ MORE

Anti-inflammatory Drug May Raise Diabetes Risk

News

A commonly prescribed anti-inflammatory drug may increase diabetes risk after just one week of treatment, according to new findings presented at The Society for Endocrinology Annual Conference.

READ MORE

The Gut Could Be Key To Cutting Chemo’s Side Effects

News

Scientists have observed several simultaneous reactions in mice given a chemotherapy drug... their gut bacteria and tissue changed, their blood and brains showed signs of inflammation, and their behaviors suggested they were fatigued and cognitively impaired.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE